UNSPSC 51473029: Benzethonium chloride

This classification denotes a topical anti-infective agent, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier PH41D05744. European Medicines Agency schedules Benzethonium chloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB05746MIG. Benzethonium chloride generally arises in the molecular formula C27H42NO2.CL. The term BENZETHONIUM CHLORIDE is an International Non-Proprietary Name or INN.

UNSPSC 51473029 Benzethonium chloride is a Commodity code that encompasses antimicrobial chemical compounds used in janitorial, operational, and healthcare supply chains. State and local governments procure benzethonium chloride primarily as a component or active ingredient within broader consumable supply categories rather than as a standalone product line. Recent solicitations show the chemical embedded in janitorial-supply contracts and pharmaceutical/OTC product agreements serving public-safety operations, healthcare facilities, and government agencies. Issuing bodies include county governments, state purchasing cooperatives, and multistate collaborative procurement alliances. The code reflects demand from operational departments — fire rescue, emergency response, and facility management — that source cleaning and antimicrobial products through competitive sealed bids and cooperative purchasing vehicles.

Geographic activity centers on Florida and Minnesota, with multistate reach through cooperative purchasing. Hillsborough County Board of County Commissioners issued an ITB on July 7, 2026 (due July 24, 2026) for consumable janitorial and operational supplies estimated at $765,679.84 annually for the Hillsborough County Fire Rescue Department's 47 fire stations in Tampa, Florida; benzethonium chloride would likely appear among approved antimicrobial agents in that supply basket. The Minnesota Multistate Cooperative Purchasing Alliance (MMCAP), administered by the Minnesota Department of Administration, issued an RFP on January 20, 2026 (due March 26, 2026) to establish multiple contracts for generic pharmaceuticals and OTC products effective July 1, 2026, with participation from Oregon and other member states; benzethonium chloride may qualify as an approved OTC antimicrobial component within that multi-award framework. Both opportunities reflect demand through as-needed replenishment contracts with no guaranteed minimums, requiring vendors to work through authorized wholesalers and meet cGMP/FDA compliance standards.